The Department of Veterans Affairs National Acquisition Center awarded Golden State Medical Supply, Inc. a single award indefinite delivery contract to supply mycophenolic acid tablets. The base period of performance is one year from April 3, 2024 to April 2, 2025, with four one-year option periods and a total potential value of $8,612,710.75. Golden State Medical Supply will provide enteric-coated mycophenolic acid tablets in 180mg and 360mg sizes to the VA, DOD, Bureau of Prisons, and Indian Health Service through the VA and DOD pharmaceutical prime vendor programs. The original pre-solicitation notice estimated annual requirements of over 15,000 bottles of 180mg tablets and over 23,000 bottles of 360mg tablets to be distributed to VA hospitals, DOD treatment facilities, prisons, and Indian Health Services centers on an as-needed basis.
The originating opportunity sought to establish a single-source supplier for mycophenolic acid tablets to ensure an uninterrupted supply for five years. The solicitation was for the NAICS code 325412, Pharmaceutical Preparation Manufacturing, with no set-aside designation. The contract facilitates orders from various agencies to acquire standard medications and products through the DLA/VA Prime Vendor formulary on an indefinite delivery, indefinite quantity basis. As the prime contractor and manufacturer, Golden State Medical Supply will leverage its distribution infrastructure to meet delivery requirements under task orders issued against the contract.
Generated 2/15/24, 9:17 AM